Accelerated Approval’s Double-Edged Sword Cuts Down Agenus’ Balstilimab BLA

 
• By Bridget Silverman
  
Russian Naval Dagger. Alamy-CPJP8D
US FDA's accelerated approval pathway offers unique benefits and vulnerabilities for sponsors. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards